The Supreme Court will soon decide on a case surrounding a medication used for abortion, mifepristone, and whether the drug should continue to be available based on claims of safety and ethical considerations. Those in favor of restrictions argue that the FDA fast-tracked its approval without considering health impacts. Those against restriction argue the FDA made its decisions based on safety and efficiency, and it’s being targeted to further infringe on women’s rights. Now we debate: Should the Courts Restrict Access to the Abortion Pill? Petitioner: Julia Kaye, Senior Staff Attorney at the ACLU Reproductive Freedom Project Respondent: Catherine Glenn Foster, Senior Fellow in Legal Policy at the Charlotte Lozier Institute Judge's Chair: John Donvan, Moderator-in-Chief and Emmy award-winning journalist Learn more about your ad choices. Visit podcastchoices.com/adchoices

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.